Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 9 - Medicinal preparations characterised by special physical form
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
12/2003
12/04/2003US20030225000 Parathyroid hormone; stabilizer, especially a polyol stabilizer; buffer to maintain the pH at 3-7; and water
12/04/2003US20030224974 Compositions for delivery of therapeutics and other materials, and methods of making and using the same
12/04/2003US20030224090 Snacks of orally soluble edible films
12/04/2003US20030224059 Drug microparticles
12/04/2003US20030224058 Nanoparticulate fibrate formulations
12/04/2003US20030224057 Continuous method for preparing pharmaceutical granules
12/04/2003US20030224056 Hemostatic composition
12/04/2003US20030224053 Mixture of a polymer, an active ingredient and a solvent capable of being preserved within a container such that on release forms a peelable, water removable, agent-releasing film on the surface of skin
12/04/2003US20030224051 Dosage forms and compositions for osmotic delivery of variable dosages of oxycodone
12/04/2003US20030224050 Drug delivery system for sustained delivery of glipizide
12/04/2003US20030224049 Modified release formulation comprising an immediate and a slow release phase; all of the potassium clavulanate and up to 50% of the amoxicillin is in the immediate release phase
12/04/2003US20030224048 Nicotine-containing, controlled release composition and method
12/04/2003US20030224047 Levothyroxine compositions and methods
12/04/2003US20030224046 Unit-dose combination composition for the simultaneous delivery of a short-acting and a long-acting oral hypoglycemic agent
12/04/2003US20030224045 Combination immediate release sustained release levodopa/carbidopa dosage forms
12/04/2003US20030224044 Drug dose-form and method of manufacture
12/04/2003US20030224043 Increasing the bioavailability of low solubility drugs, including a disintegrant and a porosigen promoting disintegrate in less than 10 minutes; high speed, drug delivery
12/04/2003US20030224042 Oral pharmaceutical composition for soft capsules containing vinorelbine and method of treatment
12/04/2003US20030224041 Emulsion formulations for hydrophilic active agents
12/04/2003US20030224039 Infusing at a low temperature below the phase transition of lipid; use for intravenous administration, inhalation administration; no toxic solvents, simple process; bactericides
12/04/2003US20030224038 Cross-linkable phosphonate-containing supramolecular complexes and their use for delivery of therapeutic and diagnostic agents
12/04/2003US20030224037 An antitumor agent oxaliplatin in transferrins liposome ligand and polyoxyethylene glycol, improving the storage stability, detoxifying and inhibiting the side effect caused by therapeutic drug
12/04/2003US20030224035 A topical or transdermal drug delivery, including an inorganic hydroxide to neutralize the acids, increase the flux of the active agent through a body surface, increase the permeability
12/04/2003US20030224033 Implantable or insertable medical devices for controlled drug delivery
12/04/2003US20030224020 Homogenizing an emulsion comprising the toxin, lactose in phosphatidylcholine liposome for drug delivery
12/04/2003US20030224008 Novel uses for anti-malarial therapeutic agents
12/04/2003US20030224006 A solid phase that is sustained by intermolecular interactions (hydrogen bonding) between two or more independent molecular entities, and at least one entity is a drug; improved drug solublity, stability, bioavailability
12/04/2003US20030224000 Methods for blocking or alleviating staphylococcal nasal colonization by intranasal application of monoclonal antibodies
12/04/2003US20030223983 Formulation comprising bioactive agents and method of using same
12/04/2003US20030223957 Bioerodible (biodegradable) polymers to address fundamental needs in ocular surgery including sealants and sealing methods, barriers to cellular adhesion and proliferation, and mechanical barriers. The present invention is directed to
12/04/2003US20030223949 Use of a polypeptide for treatment of pruritus in animals
12/04/2003US20030223939 Particulate materials
12/04/2003US20030223938 Relates to nanoparticles comprised of a carrier, particularly polymerized lipids, and ligands displayed on the carrier, wherein the ligands form a polyvalent binding unit that is effective to produce a specific interaction between the
12/04/2003US20030223937 Cationic quaternary ammonium heterocyclic compounds with steroid compound for respiratory system disorders
12/04/2003US20030223936 Compositions methods and systems for pulmonary delivery of recombinant human interferon alpha-2b
12/04/2003US20030222364 Method and apparatus for producing dry particles
12/04/2003DE20216314U1 Pure, free-flowing, spray-dried xylitol powder with rough surface structure, useful for production of binder-free tablets for use in the pharmaceutical or food industry
12/04/2003CA2496618A1 Use of a parathyroid hormone peptide analogs for the treatment of vaginal atrophy
12/04/2003CA2487287A1 Container for the generation of therapeutic microfoam
12/04/2003CA2487283A1 Method for assembling sub units into capsoides
12/04/2003CA2487279A1 Progestagenic dosage units
12/04/2003CA2487269A1 Novel exendin agonist formulations and methods of administration thereof
12/04/2003CA2487153A1 New formulation for the parenteral application of crobenetine
12/04/2003CA2487117A1 Method for preparing polymer micelle pharmaceutical preparation containing drug for injection
12/04/2003CA2487070A1 Aqueous fludarabine phosphate composition
12/04/2003CA2486967A1 Cardiolipin compositions their methods of preparation and use
12/04/2003CA2486909A1 Compositions and method for transmucosal drug delivery and cryoprotection
12/04/2003CA2486622A1 Aerosol drug inhibition of lung metastases
12/04/2003CA2486613A1 Chewable compositions containing a gel-forming extract of psyllium
12/04/2003CA2486113A1 Injectable solid hyaluronic acid carriers for delivery of osteogenic proteins
12/04/2003CA2484274A1 Compositions and methods of use for a fibroblast growth factor
12/04/2003CA2481394A1 Drop-forming ophthalmic gel preparation comprising diclofenamide and timolol
12/03/2003EP1366783A1 Medicinal herbal preparation for disinfecting vaginas
12/03/2003EP1366768A1 Compositions for therapeutic use comprising a vitamin, a metal salt and insulin or a growth hormone
12/03/2003EP1366767A1 Aqueous suspension eyedrops and process for producing the same
12/03/2003EP1366762A1 Adhesive patch
12/03/2003EP1366761A1 Gel preparations for internal use
12/03/2003EP1366760A1 Tablets quickly disintegrated in oral cavity
12/03/2003EP1366759A1 Tablets quickly disintegrating in oral cavity
12/03/2003EP1366758A1 Novel ophthalmic compositions
12/03/2003EP1366455A2 Method for identification of t-cell epitopes and use for preparing molecules with reduced immunogenicity
12/03/2003EP1366075A2 New interferon beta-like molecules
12/03/2003EP1365812A2 Pharmaceutical composition having reduced tendency for drug crystallization
12/03/2003EP1365811A2 Compositions containing alpha-2-adrenergic agonist components
12/03/2003EP1365778A2 Treating pulmonary disorders with gaseous agent causing repletion of gsno
12/03/2003EP1365775A1 Telithromycin suspension with a masked taste
12/03/2003EP1365772A2 Stabilized brivudine topical formulations containing metal oxide pigments
12/03/2003EP1365770A2 Devices and methods for management of bone density
12/03/2003EP1365766A2 Pharmaceutical composition for treatment of phimosis using topical corticosteroid
12/03/2003EP1365764A1 Oral pharmaceutical composition of cefpodoxime proxetil
12/03/2003EP1365761A1 Therapeutic combination of amlodipine and benazepril
12/03/2003EP1365759A2 Chemotherapeutic microemulsion compositions of paclitaxel with improved oral bioavailability
12/03/2003EP1365751A2 Granules and granules coated with a masked taste
12/03/2003EP1365750A2 Methods for inactivation of pathogens in biological materials
12/03/2003EP1365749A2 Process for preparing pharmaceutical compositions for use with soft gelatin formulations
12/03/2003EP1365748A2 Particulate composition of eletriptan showing a sigmoidal pattern of controlled release
12/03/2003EP1365747A1 Oral peptide pharmaceutical dosage form and method of production
12/03/2003EP1365746A1 Pharmaceutical composition which comprise a solid dispersion of a hydroxypropylmethylcellulose phthalate polymer
12/03/2003EP1365745A2 Stabilized pharmaceutical and thyroid hormone compositions and method of preparation
12/03/2003EP1365744A2 Method of producing porous tablets with improved dissolution properties
12/03/2003EP1365743A2 Fast dissolving tablet
12/03/2003EP1365740A1 Rapid-onset medicament for the treatment of sexual dysfunction
12/03/2003EP1365739A1 Composition for rectal delivery of an oxazolidinone antibacterial drug
12/03/2003EP1365738A2 Improved process for the production of sustained release drug delivery devices
12/03/2003EP1365737A2 Stable salts of o-acetylsalicyclic with basic amino acids
12/03/2003EP1365735A1 Water-in-oil emulsions containing one or more ammonium acryloyl dimethyltaurates or vinyl pyrrolidone copolymers
12/03/2003EP1365716A1 Biodegradable cationic copolymers of poly(alkylenimine) and poly(ethylene glycol) for the delivery of bioactive agents
12/03/2003EP1365713A1 Urine incontinence device and corresponding method
12/03/2003EP1365705A1 Injectable pharmaceutical composition comprising microparticles or microdroplets of camptothecin
12/03/2003EP1365704A2 Radiation cross-linked hydrogels
12/03/2003EP1365651A1 Composition and methods for modulation of vascular structure and/or function
12/03/2003EP1250125B1 Pharmaceutical compositions comprising terbinafine
12/03/2003EP1212336B1 Method for the production and use of spherical telithromycin clusters in the preparation of pharmaceutical forms
12/03/2003EP1140050B1 A composition useful to treat periodontal disease
12/03/2003EP1117516B1 A method for producing a layered product
12/03/2003EP1112052B1 Method and device for producing tablets
12/03/2003EP1045709B1 Method and device for in-situ formulation of a medicinal solution for parenteral application
12/03/2003EP1027037B1 Pharmaceutical preparation comprising clodronate as active ingredient and silicified microcrystalline cellulose as excipient
12/03/2003EP0971702B1 Microgranules containing cisplatin
12/03/2003EP0854705B1 Hormone dispenser for hormone replacement therapy method
1 ... 2059 2060 2061 2062 2063 2064 2065 2066 2067 2068 2069 2070 2071 2072 2073 2074 2075 2076 2077 2078 2079 ... 2991